PALATIN TECHNOLOGIES, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
PALATIN TECHNOLOGIES, INC. (PTN) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2024-09-30
- PALATIN TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-06-30 was $1.25M.
- PALATIN TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-12-31 was $36.72K.
- PALATIN TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-09-30 was $56.72K.
- PALATIN TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $368.98K.
- PALATIN TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- PALATIN TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $365.88K, a 72.69% decline from fiscal 2020.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 10-K · filed 2024-09-30 | |||
| 2023-06-30 | $368.98K 10-K · filed 2024-09-30 | |||
| 2022-06-30 | $0.00 10-K · filed 2023-09-28 | |||
| 2021-06-30 | $365.88K 10-K · filed 2022-09-22 | |||
| 2020-06-30 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $1.25M derived: sum of 2 quarters · filed 2021-09-28 | $1.28M derived: sum of 3 quarters · filed 2021-09-28 | $1.34M 10-K · filed 2021-09-28 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $36.72K derived: sum of 2 quarters · filed 2020-05-11 | $93.44K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $36.72K 10-Q · filed 2020-02-10 | $93.44K 10-Q · filed 2020-02-10 | ||
| 2019-09-30 | $56.72K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |